Price
37.66
-0.35%52W Range
Market Cap
0 Cr
Traded: ₹0.14 Cr (Infinity%) 0.0x
Volume · 60D trend
36.77 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -- | -- | -- | -- | -- | -- |
| Sales | +15.0% | +7.0% | -3.0% | -- | +7.0% | Stable |
| Profit | +7.0% | -- | +17.0% | -- | +82.0% | Accelerating |
| Return | +10.0% | -2.0% | +16.0% | +18.0% | -- | Accelerating |
Quarterly Results
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 136 | 147 | 126 | 164 | 137 | 165 | 175 | 59 | 183 | 187 | 189 | 145 | 194 | 174 | 139 |
| Expenses | 120 | 151 | 143 | 177 | 173 | 191 | 175 | 83 | 183 | 190 | 177 | 154 | 177 | 173 | 157 |
| Operating Profit | 17 | -4 | -17 | -13 | -37 | -26 | 0 | -24 | -1 | -3 | 11 | -9 | 16 | 1 | -17 |
| OPM % | 12.0% | -2.0% | -14.0% | -8.0% | -27.0% | -16.0% | 0.0% | -40.0% | 0.0% | -2.0% | 6.0% | -6.0% | 8.0% | 1.0% | -12.0% |
| Other Income | 4 | 5 | 5 | 13 | 551 | -35 | 5 | 5 | 7 | 4 | 5 | 3 | -5 | 3 | 9 |
| Interest | 5 | 5 | 5 | 5 | -10 | 18 | 18 | 16 | 17 | 18 | 17 | 17 | 17 | 17 | 13 |
| Depreciation | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 15 | -4 | -18 | -6 | 523 | -79 | -14 | -35 | -12 | -18 | -2 | -23 | -6 | -14 | -21 |
| Tax % | -7.0% | 0.0% | 0.0% | 0.0% | 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | 16 | -4 | -18 | -6 | 520 | -79 | -14 | -35 | -12 | -18 | -2 | -23 | -6 | -14 | -21 |
| Exceptional Items | 0 | -0 | -0 | 7 | 545 | -43 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | 0 | 0 |
| EPS (Rs) | 2.3 | -0.6 | -2.7 | -0.9 | 77.4 | -11.8 | -2.0 | -5.3 | -1.8 | -2.6 | -0.2 | -3.4 | -0.6 | -2.0 | -3.1 |
| Sales Growth (YoY) | -0.7% | -10.9% | -28.0% | 178.0% | -25.1% | -11.8% | -7.4% | -59.3% | -5.7% | 7.5% | 36.0% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -7.5% | 16.7% | -23.2% | 19.7% | -17.0% | -5.7% | 196.6% | -67.8% | -2.1% | -1.1% | 30.3% | -25.3% | 11.5% | 25.2% | -- |
| OP Growth (YoY) | 145.9% | 84.6% | -- | 45.8% | -3600.0% | -766.7% | -100.0% | -166.7% | -106.3% | -400.0% | 164.7% | -- | -- | -- | -- |
| OP Growth (QoQ) | 525.0% | 76.5% | -30.8% | 64.9% | -42.3% | -- | 100.0% | -2300.0% | 66.7% | -127.3% | 222.2% | -156.3% | 1500.0% | 105.9% | -- |
| Profit Growth (YoY) | 169.0% | 90.0% | -28.0% | 61.0% | -81.0% | -99.0% | -896.0% | -53.0% | -557.0% | -34.0% | 93.0% | -61.0% | -106.0% | 34.3% | -105.6% |
| EPS Growth (YoY) | -97.0% | 95.1% | -33.0% | 82.2% | 4472.3% | -343.8% | -866.7% | -53.2% | -180.9% | -31.8% | 93.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 503.4% | 78.5% | -187.2% | -101.2% | 758.1% | -479.3% | 61.5% | -197.7% | 33.2% | -1161.9% | 93.9% | -446.0% | 68.7% | 35.6% | -- |
| OP Margin | 12.5% | -2.7% | -13.5% | -7.9% | -27.0% | -15.8% | 0.0% | -40.7% | -0.6% | -1.6% | 5.8% | -6.2% | 8.3% | 0.6% | -12.2% |
| Net Margin | 11.8% | -2.7% | -14.3% | -3.7% | 379.6% | -47.9% | -8.0% | -59.3% | -6.6% | -9.6% | -1.1% | -15.9% | -3.1% | -8.1% | -15.1% |
| Material Cost % | 58.0% | 70.0% | 80.0% | 78.0% | 81.0% | 85.0% | 70.0% | 78.0% | 73.0% | 73.0% | 64.0% | 74.0% | 68.0% | 72.0% | 74.0% |
| Employee Cost % | 7.0% | 8.0% | 9.0% | 7.0% | 9.0% | 7.0% | 7.0% | 20.0% | 5.0% | 6.0% | 7.0% | 7.0% | 4.0% | 6.0% | 12.0% |
| P/S | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Appointment of Smt. Sarita Gena as non official independent director on the Board of HOCL w.e.f. 14.08.2026.
Intimation for 65th AGM hereby submitted.
Newspaper publishing of Q 1 financial results submitted for records.
Financial Results for Q1
Decision of the Board is submitted for kind information.
Pay revision communication received from Administrative Ministry is hereby submitted.
Outcome of Board Meeting and Financial Results.
HOCL certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Q1 ended 30th June, 2026 is hereby submitted
Reopening of HOCL Plants at Kochi unit is hereby submitted
BSE intimation regarding closure of trading window for the 1st Quarter ended 30/06/2026 for the FY 2026-27
Intimation regarding initiation of the temporary shut down activities of Phenol plant is hereby informed.
The phenol plant of HOCL has been re-opened with effect from 12th June 2026 for commercial production.
Completion of tenure of Shri Vinay Kumar Sharma as Independent Director is hereby submitted
Continuation of plant shutdown from 01.06.2026 is hereby submitted
Annual Secretarial Compliance Report is hereby submitted
Temporary shutdown of HOCL phenol plant for 10 days is hereby submitted
Comments of Board regarding the fine imposed by BSE is hereby submitted.
Newspaper advertisement of financial results
Financial results
Outcome of the Board meeting
Commencement of Commercial Production of HOCL Phenol & Cumemen Plant from 24-04-2026.
Hindustan Organic Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve Audited Financial ....
Intimation regarding re-opening of HOCL Phenol & cumene PLANT
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 of HOCL for the Q4 of the FY 2025-26 is hereby submitted.
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
HOCL Intimation regarding Trading Window Closure of Q4 of the Financial Year 2025-2026
Intimation regarding LOI placed with the party is hereby submitted
The Plant shutdown intimation is hereby submitted.
Newspaper advertisement done by the Merchant Banker on behalf of HOCL in the process of delisting of the subsidiary company is hereby submitted.
Temporary shutdown of Cumene Plant of HOCL from today (11th March 2026).
The Plant shutdown intimation due to the interruption in LPG supply is submitted
News paper advertisement regarding intimation of Special Window for Transfer and Dematerialisation of Shares hereby Submitted.
News paper advertisement regarding intimation of Special Window for Transfer and Dematerialisation of Shares hereby Submitted.
Newspaper Advertisement regarding Public Announcement in the matter of delisting of subsidiary company
Outcome of Board meeting along with financial results is hereby submitted
Financial results is hereby submitted
Revised financial results with signed limited review report is submitted.
Reappointment of RTA approved by the Board is hereby submitted
The payment remitted in the Small Causes Court at Mumbai in connection with a long pending litigation is reported.
Hindustan Organic Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Q 3 financial results ....
certificate under Reg. 74(5) of SEBI (DP)regulations, 2018 for the 3rd Quarter ended 31-12-2025 of FY 2025-26. is hereby submitted.
Change in Senior Management personnel of the company due to retirement is hereby submitted.
Trading window closure for Q 3 of FY 2025-26 is hereby submitted
The comments of the Board w.r.t fine imposed by BSE for Q 1 for non-compliance of SEBI LODRR is hereby submitted
HOCL Q 2 financial results are hereby submitted
Outcome of Board meeting is hereby submitted
Hindustan Organic Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Un-audited Q2 Financial ....
Appointment of CMD and cessation of additional charge given to Shri Yogendra Prasad Shukla is hereby submitted
Compliance certificate is hereby submitted